Published by Coherent Market Insights
Posted on September 27, 2021
4 min readLast updated: February 2, 2026
The Adipose Stem Cell Therapy market is set to grow by 2027, driven by advancements in regenerative medicine and key industry players.
Adipose Derived Stem Cell Therapy Market report includes historic data, present market trends, environment, technological innovation, upcoming technologies and the technical progress in the related industry. Adipose Derived Stem Cell Therapy Market offers complete, proficient report delivering market research data that is relevant for new market entrants or set up players. Key strategies of the companies operating in the market and their impact analysis have been included in the report.
Request for Sample Copy of Report at – https://www.coherentmarketinsights.com/insight/request-sample/2357
Adipose derived stem cells (ADSCs) are stem cells derived from adipocytes, and can differentiate into variety of cell types. ADSCs have multipotency similar to bone marrow mesenchymal stem cells, thus ADSCs substitute for bone marrow as a source of stem cells. Numerous manual and automatic stem cell separation procedures are adopted in order to separate adipose stem cells (ASCs) from adipose tissue. Flow cytometry can also be used to isolate ADSCs from other stem cells within a cell solution.
Adipose derived stem cells are gaining appeal as a new cell source in regenerative medicine therapies as it can be differentiated into a variety of different cell lineages. These stem cells also have anti-apoptotic, anti-inflammatory, pro-angiogenic, immunomodulatory, and anti-scarring properties, which enhances its effectiveness.
Adipose Derived Stem Cell Therapy Market Drivers
High effectiveness of adipose derived stem cell therapy in various medical and biotechnology research fields coupled with growing research and development activities by various research organizations is expected to boost the adoption of adipose-derived stem cell therapy in the market during the forecast period. Adipose derived stem cells (ADSCs) have various applications in medical and biomedical science field such as treatment of diabetes; regeneration of tissues partially in osteogenic, adipogenic, chondrogenic, and cardiovascular areas of medicine; bone regeneration; fat reconstruction; and myocardial and cardiovascular regeneration; among others.
For instance, in November 2018, a peer-reviewed case study conducted using a stem cell processed by Celltex Therapeutics Corporation, showed the improvement in disease findings following systemic administration of autologous adipose derived mesenchymal stem cells (MSCs).
Major Key Players are: DePuy Synthes, Zimmer Biomet Holdings, KLS Martin Group, A&E Medical, Orthofix International N.V., Kinamed Incorporated, Abyrx, Inc., Acute Innovations LLC, Praesidia SRL, and Idear SRL.
Intent of the Adipose Derived Stem Cell Therapy Market Research Study:
Purchase this Premium Report (Flat USD 2000 OFF) – https://www.coherentmarketinsights.com/promo/buynow/2357
Reasons to Purchase this Report
Contact US:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Adipose Derived Stem Cell Therapy Market 2027 Application, Consumption, Market Share, Growth Opportunities, Regions appeared first on Gatorledger.
The article focuses on the growth and opportunities in the Adipose Derived Stem Cell Therapy market by 2027.
ADSCs are used in diabetes treatment, tissue regeneration, and cardiovascular medicine.
Major players include DePuy Synthes, Zimmer Biomet Holdings, and KLS Martin Group.
Explore more articles in the Research Reports category
